Seelos Therapeutics, Inc. Debt Conversion, Original Debt, Amount
Seelos Therapeutics, Inc. reported Debt Conversion, Original Debt, Amount of $3.50 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2023-11-14
- Seelos Therapeutics, Inc. debt conversion, original debt, amount for the quarter ending 2023-09-30 was $800.00K.
- Seelos Therapeutics, Inc. debt conversion, original debt, amount for the quarter ending 2013-12-31 was $0.00.
- Seelos Therapeutics, Inc. debt conversion, original debt, amount for the quarter ending 2013-09-30 was $0.00.
- Seelos Therapeutics, Inc. debt conversion, original debt, amount for the quarter ending 2013-06-30 was $1.15M.
- Seelos Therapeutics, Inc. debt conversion, original debt, amount for fiscal 2013 was $1.25M.
- Seelos Therapeutics, Inc. debt conversion, original debt, amount for fiscal 2012 was $0.00.
| Period end | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 6 month | Debt Conversion, Original Debt, Amount 9 month | Debt Conversion, Original Debt, Amount 12 month |
|---|---|---|---|---|
| 2023-09-30 | $800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $3.50M 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | $2.70M 10-Q · filed 2023-08-11 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $1.15M derived: sum of 3 quarters · filed 2015-03-16 | $1.25M 10-K · filed 2015-03-16 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $1.15M derived: sum of 2 quarters · filed 2013-11-12 | $1.25M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $1.25M 10-Q · filed 2013-08-14 | ||
| 2013-03-31 | $100.00K 10-Q · filed 2013-05-10 | |||
| 2012-12-31 | $0.00 10-K · filed 2014-03-17 |